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AMPKAutophagy, a conservative degradation process for long-lived and damaged proteins, participates in a variety of
biological processes including obesity. However, the precisemechanism of action behind obesity-induced chang-
es in autophagy still remains elusive. This study was designed to examine the role of the antioxidant catalase in
high fat diet-induced changes in cardiac geometry and function as well as the underlying mechanism of action
involvedwith a focus on autophagy.Wild-type (WT) and transgenicmicewith cardiac overexpression of catalase
were fed low or high fat diet for 20 weeks prior to assessment ofmyocardial geometry and function. High fat diet
intake triggered obesity, hyperinsulinemia, and hypertriglyceridemia, the effects of which were unaffected by
catalase transgene. Myocardial geometry and function were compromised with fat diet intake as manifested
by cardiac hypertrophy, enlarged left ventricular end systolic and diastolic diameters, fractional shortening, car-
diomyocyte contractile capacity and intracellular Ca2+ mishandling, the effects of which were ameliorated by
catalase. High fat diet intake promoted reactive oxygen species production and suppressed autophagy in the
heart, the effects of which were attenuated by catalase. High fat diet intake dampened phosphorylation of inhib-
itor kappa B kinase β(IKKβ), AMP-activated protein kinase (AMPK) and tuberous sclerosis 2 (TSC2) while
promoting phosphorylation of mTOR, the effects of which were ablated by catalase. In vitro study revealed that
palmitic acid compromised cardiomyocyte autophagy and contractile function in a manner reminiscent of fat
diet intake, the effect ofwhichwas signiﬁcantly alleviated by inhibition of IKKβ, activation of AMPK and induction
of autophagy. Taken together, our data revealed that the antioxidant catalase counteracts against high fat diet-
induced cardiac geometric and functional anomalies possibly via an IKKβ-AMPK-dependent restoration of myo-
cardial autophagy. This article is part of a Special Issue entitled: Autophagy and protein quality control in cardio-
metabolic diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Autophagy is a conservative bulk degradation cellular process to
clear long-lived proteins and organelles [1]. It is well conceived thaty and protein quality control in
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ular Research and Alternative
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zhangym197951@126.comautophagy plays a pivotal role in both physiological and pathological
conditions such as development, immunity, cancer, nutrient deﬁciency,
aging and neurodegenerative diseases [2–4]. A number of cell signaling
molecules have been identiﬁed participating in the regulation of au-
tophagy. The serine/threonine kinase, mammalian target of rapamycin
(mTOR) serves as perhaps the most predominant signaling molecule
to negatively regulate autophagy through mTOR complex 1 (mTORC1)
[1,5,6]. It is known that mTORC1maymediate the regulation of autoph-
agy in response to rapamycin, starvation, growth factors, amino acids,
and energy excess, through a cascade of autophagy signaling including
mammalian Atg13, ULK1 and FIP200 [1,2,6]. Evidence further depicted
a role for IκB kinase (IKK) in the regulation of autophagy through a
mechanism independently of nuclear factor κ B (NFκB) [3]. Although
autophagy serves as a housekeeper under physiological condition to
maintain cardiac homeostasis [7], dysregulated especially excessive
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such as ischemia/reperfusion injury, dilated cardiomyopathy, alcoholic
cardiomyopathy, myocardial hypertrophy and heart failure [8–10].
Up-to-date, the precise role of autophagy and the underlying autophagy
regulatory mechanisms remain essentially unclear in obesity-induced
myocardial anomalies. Epidemiological survey has revealed that ap-
proximately 35% of the US population are considered obese or over-
weight [11–14]. Not surprisingly, uncorrected obesity is deemed an
independent risk factor for the pathogenesis of cardiovascular compli-
cations leading to high morbidity and mortality in obese populations.
Severalmechanisms have been postulated for the etiology of obesity co-
morbidities including c-Jun N terminal kinase (JNK) activation [15–17],
protein kinase C induction [18,19], oxidative stress [20,21], altered
substrate metabolism [22] and dysregulation of autophagy [23–25].
To this end, the present work was designed to examine the possible
impact of antioxidant catalase in the regulation of cardiac autophagy
and homeostasis in the face of high fat diet-induced obesity. To eval-
uate a possible role of the antioxidant catalase in the regulation of
myocardial autophagy and function, wild-type (WT) and transgenic
mice with cardiac-speciﬁc overexpression of catalase were fed low
or high fat diet for 20 weeks. Plasma proﬁle, cardiac geometry,
contractile function, cardiomyocyte contractile properties and intra-
cellular Ca2+ homeostasis, production of reactive oxygen species
(ROS) and autophagy were examined. The mTOR-dependent
(IKKβ-AMPK-TSC-Rheb-mTOR) autophagy regulatory machinery
was examined in an effort to discern high fat diet- and catalase-
induced changes in myocardial autophagy and function in WT and
catalase transgenic mice.
2. Methods and materials
2.1. Experimental animals and high fat diet feeding
The animal procedures described herewere approved by the Institu-
tional Animal Care and Use Committee at the University of Wyoming
(Laramie, WY, USA). Cardiac-speciﬁc catalase overexpression mice
were used as described [26,27]. FVB littermates were used as wild-
type. A primer pair derived from the MHC promoter and rat catalase
cDNAwas used for identiﬁcation of catalase transgene with the reverse
sequence of 5′-aat atc gtg ggt gac ctc aa-3′ and the forward sequence of
5′-cag atg aag cag tgg aag ga-3′. All micewere housed in a temperature-
controlled room under a 12 h/12 h-light/dark and allowed access to
food and tap water ad libitum. Five-week-old male WT and catalase
transgenic mice were subjected to a normal (10% calories from fat,Table 1
Biometric and myocardial contractile parameters of WT and catalase (CAT) transgenic mice fed
Parameter WT-low fat
Body weight (g) 26.0 ± 0.5
Heart weight (mg) 143 ± 4
Heart/body weight (mg/g) 5.50 ± 0.10
Heart/tibial length (mg/mm) 8.21 ± 0.23
Liver weight (g) 1.33 ± 0.02
Liver/body weight (mg/g) 51.4 ± 1.0
Kidney weight (g) 0.380 ± 0.010
Kidney/body weight (mg/g) 15.2 ± 0.6
Fasting blood glucose (mg/dl) 102.3 ± 3.9
Plasma insulin (ng/ml) 0.254 ± 0.030
Plasma triglycerides (mg/dl) 43.1 ± 4.0
Cardiac catalase activity (μmol/min/mg protein) 36.8 ± 3.3
Heart rate (bpm) 445 ± 26
LV wall thickness (mm) 1.14 ± 0.15
LVESD (mm) 1.09 ± 0.07
LVEDD (mm) 2.03 ± 0.08
Fractional shortening (%) 50.3 ± 1.4
HW = heart weight; Mean ± SEM, n = 11–12 mice per group, *p b 0.05 vs. WT-Low fat grou3.91 kcal/g) or high fat (45% calories from fat, 4.83 kcal/g; Research
Diets, New Brunswick, NJ, USA) diet feeding for 20 weeks [28]. Plasma
levels of glucose, insulin and triglycerides were measured using com-
mercial kits.
2.2. Catalase activity
Myocardial tissues were homogenized in 1% Triton X-100 in an
assay buffer described below using a variable-speed tissue tearer
(Biospec Products, Racine, WI) at 20,000 rpm for 30 s on ice. The
homogenates were centrifuged at 6000 ×g at 4 °C for 20 min. The
supernatant was diluted with 1.5 volumes of the assay buffer
(50 mM KH2PO4/50 mM Na2HPO4, pH 7.0). The enzyme activity
was determined by the method described previously [29].
Brieﬂy, in a cuvette 2 ml of sample was added and the reaction
was initiated by adding 1 ml 30 mM H2O2 and the change in absor-
bance at 240 nm was monitored at 25 °C for 1 min. A portion of the
remaining sample was used for protein determination. Speciﬁc ac-
tivity is expressed as μmole H2O2/min/mg protein.
2.3. Echocardiographic assessment
Cardiac geometry and contractile function were evaluated in anes-
thetized (ketamine 80 mg/kg and xylazine 12 mg/kg, i.p.) mice using
a 2-D guided M-mode echocardiography (Sonos 5500) equipped with
a 15–6 MHz linear transducer. Diastolic and systolic left ventricular
(LV) dimensions were recorded from M-mode images using method
adopted by the American Society of Echocardiography [30]. Fractional
shortening was calculated from end-diastolic diameter (EDD) and
end-systolic diameter (ESD) using the equation of (EDD− ESD) / EDD
[29].
2.4. Isolation of mouse cardiomyocytes and in vitro drug treatment
Hearts were mounted onto a temperature-controlled (37 °C)
Langendorff system. After perfusion with a modiﬁed Tyrode's solution,
the heart was digested with a Ca2+-free KHB buffer containing liberase
blendzyme 4 (Hoffmann-La Roche Inc., Indianapolis, IN) for 20min. The
modiﬁed Tyrode solution (pH 7.4) contained the following (in mM):
NaCl 135, KCl 4.0, MgCl2 1.0, HEPES 10, NaH2PO4 0.33, glucose 10,
butanedione monoxime 10, and the solution was gassed with 5% CO2/
95% O2. The digested heart was then removed from the cannula and
the left ventricle was cut into small pieces in the modiﬁed Tyrode's so-
lution. Tissue pieces were gently agitated and pellet of cells wasa low or high fat diet for 20 weeks.
WT-high fat CAT-low fat CAT-high fat
32.4 ± 0.8⁎ 25.8 ± 0.5 31.4 ± 0.6⁎
178 ± 4⁎ 143 ± 4 161 ± 3⁎,⁎⁎
5.49 ± 0.09 5.58 ± 0.22 5.16 ± 0.13
9.94 ± 0.33⁎ 8.09 ± 0.21 8.88 ± 0.15⁎,#
1.63 ± 0.03⁎ 1.30 ± 0.05 1.57 ± 0.03⁎
50.7 ± 1.6 50.5 ± 2.2 50.2 ± 1.5
0.480 ± 0.010⁎ 0.389 ± 0.012 0.488 ± 0.014⁎
14.9 ± 0.6 15.1 ± 0.5 15.6 ± 0.5
100.1 ± 4.1 99.1 ± 4.1 97.0 ± 4.1
0.698 ± 0.073⁎ 0.351 ± 0.053 0.717 ± 0.076⁎
104.8 ± 5.0⁎ 46.9 ± 6.1 106.1 ± 7.7⁎
24.4 ± 3.3⁎ 184.9 ± 17.6⁎ 184.0 ± 17.2⁎
452 ± 18 453 ± 27 459 ± 22
1.14 ± 0.05 1.03 ± 0.06 1.02 ± 0.04
1.58 ± 0.19⁎ 1.10 ± 0.06 1.15 ± 0.06#
2.49 ± 0.18⁎ 2.09 ± 0.10 2.26 ± 0.10⁎,#
37.6 ± 3.9⁎ 47.2 ± 2.5 49.2 ± 0.6#
p, #p b 0.05 vs. WT-High fat group.
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clear sacromere striations was achieved. Only rod-shaped myocytes
with clear edges were selected for contractile studies [31]. To eluci-
date the role for IKKβ, AMPK and autophagy in fat diet-induced re-
sponse on cardiomyocyte autophagy and contractile function,
cardiomyocytes from WT mice were treated with palmitic acid
(75 μM) [32] for 6 h in the presence or absence of the IKKβ inhibitor
(phosphorylation stimulator) sodium salicylate (5 mg/ml) [33], the
AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside
(AICAR, 500 μM) [34,35] or the autophagy inducer rapamycin (20 μM)
[34] prior to assessment of cardiomyocyte autophagy (using LC3II-to-
LC3I ratio) and function.2.5. Cell shortening/relengthening
Mechanical properties of cardiomyocytes were assessed using a
SoftEdge MyoCam® system (IonOptix Corporation, Milton, MA, USA)
[29]. Cells were placed in a Warner chamber mounted on the stage of
an inverted microscope (Olympus, IX-70) and superfused (~1 ml/minFig. 1. Cardiomyocyte mechanical function inWT and catalase transgenic mice fed low or high
length); C:maximal velocity of shortening (+dL/dt); D:maximal velocity of relengthening (−d
cells from 4 mice per group, *p b 0.05 vs.WT-low fat group, #p b 0.05 vs.WT-high fat group.at 25 °C) with a buffer containing (in mM): 131 NaCl, 4 KCl, 1 CaCl2,
1 MgCl2, 10 glucose, and 10 HEPES, at pH 7.4. The cells were ﬁeld stim-
ulatedwith supra-threshold voltage at a frequency of 0.5 Hz and a dura-
tion of 3 msec. The cardiomyocyte being studied was displayed on a
computer monitor using an IonOptix MyoCam camera. An IonOptix
SoftEdge software was used to capture changes in cell length during
shortening and relengthening. Cell shortening and relengthening were
assessed using the following indices: peak shortening (PS), time-to-PS
(TPS), time-to-90% relengthening (TR90), maximal velocities of shorten-
ing (+dL/dt) and relengthening (−dL/dt).2.6. Intracellular Ca2+ transients
Isolated cardiomyocytes were loaded with fura-2/AM (0.5 μM)
for 10 min, and ﬂuorescence intensity was recorded with a dual-
excitation ﬂuorescence photomultiplier system (IonOptix). Myocytes
were placed onto an Olympus IX-70 inverted microscope and imaged
through a Fluor 40x oil objective. Cells were exposed to light emitted
by a 75-W lamp and passed through either a 360- or a 380-nm ﬁlterfat diet for 20 weeks. A: Resting cell length; B: peak shortening (normalized to resting cell
L/dt); E: time-to-PS (TPS); and F: time-to-90% relengthening (TR90). Mean± SEM, n=94
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were detected between 480 and 520 nm, and qualitative change in
fura-2 ﬂuorescence intensity was inferred from the fura-2 ﬂuorescence
intensity ratio at the 2wavelengths (360/380). Fluorescence decay time
was calculated as an indicator of intracellular Ca2+ clearing [36].
2.7. Histological examination
Following anesthesia, hearts were excised and immediately placed
in 10% neutral-buffered formalin at room temperature for 24 h after a
brief rinse with PBS. The specimen was embedded in parafﬁn, cut in
5-μm sections and stained with hematoxylin and eosin (H&E). Cardio-
myocyte cross-sectional areas were calculated on a digital microscope
(×400) using the Image J (version 1.34S) software [37].
2.8. Generation of intracellular reactive oxygen species (ROS)
To evaluate the generation of myocardial ROS, freshly frozen left
ventricular myocardium (10-μm slices) was incubated for 1 h at 37 °C
with 5-(6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein diacetate
(DCF, 4 μM,Molecular Probes, Eugene, OR, USA) [38]. Tissueswere sam-
pled using an Olympus BX-51 microscope equipped with an Olympus
MagnaFire™ SP digital camera and ImagePro image analysis software
(Media Cybernetics, Silver Spring, MD, USA). Fluorescence was calibrat-
ed with InSpeck microspheres (Molecular Probes).
2.9. Western blot analysis
Murine heart tissues or dispersed cardiomyocytes were homogenized
and sonicated in a lysis buffer containing 20 mM Tris (pH 7.4), 150 mM
NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton, 0.1% sodium dodecyl sulfate
(SDS), and a protease inhibitor cocktail. Samples were incubated with
anti-Atg5, anti-Beclin-1, anti-LC3, anti-p62, anti-Rheb, anti-IKKβ, anti-Fig. 2. Intracellular Ca2+ property in cardiomyocytes from WT and catalase transgenic mic
B: electrically-stimulated rise in FFI (ΔFFI); C: single exponential intracellular Ca2+ decay; an
per group, *p b 0.05 vs.WT-low fat group, #p b 0.05 vs.WT-high fat group.phosphorylated IKKβ (pIKKβ, Ser180), anti-AMPK, anti-phosphorylated
AMPK (pAMPK, Thr172), anti-mTOR, anti-phosphorylated mTOR (pmTOR,
Ser2448), anti-TSC2, anti-phosphorylated TSC2 (pTSC2, Ser1387) and anti-
GAPDH (as loading control) antibodies. The membranes were incubated
with horseradish peroxidase (HRP)-coupled secondary antibodies. After
immunoblotting, the ﬁlm was scanned and detected with a Bio-Rad Cali-
bratedDensitometer and the intensity of immunoblot bandswas normal-
ized to that of GAPDH [38].
2.10. Data analysis
Data were Mean ± SEM. Statistical signiﬁcance (p b 0.05) was esti-
mated by one-way analysis of variation (ANOVA) followed by a Tukey's
test for post hoc analysis.
3. Results
3.1. Effect of catalase overexpression on biometric properties and
echocardiographic function following high fat diet feeding
Chronic high fat diet intake overtly increased body and organ
weights (heart, liver and kidney) aswell as heartweight-to-tibial length
ratio (although not organ-to-body weight ratio), the effects of which
were unaffected by catalase overexpression. Catalase transgene did
not affect body or organ weights under low fat diet intake. Plasma glu-
cose levels were comparable in all mouse groups. High fat diet feeding
overtly elevated plasma levels of insulin and triglycerides. Catalase
transgene did not affect levels of insulin and triglycerides in either WT
or catalasemice. High fat diet intake signiﬁcantly suppressedmyocardi-
al catalase activity, the effect of which was masked by cardiac catalase
overexpression. Echocardiographic analysis revealed that high fat diet
feeding signiﬁcantly decreased fractional shortening as well as in-
creased LV end-diastolic diameter (LVEDD), LV end-systolic diametere fed low or high fat diet for 20 weeks. A: Resting fura-2 ﬂuorescence intensity (FFI);
d D: bi-exponential intracellular Ca2+ decay. Mean ± SEM, n = 56–57 cells from 4 mice
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self failed to elicit any notable effect on these echocardiographic param-
eters, it signiﬁcantly attenuated high fat diet-induced
echocardiographic changes (Table 1).
3.2. Effect of catalase overexpression on cardiomyocyte mechanics following
high fat diet feeding
To evaluate the effect of catalase transgene on high fat diet-induced
cardiac responses, cardiomyocyte mechanical function was assessed in
WT or catalase transgenic mice with low or high fat diet intake. Our
data revealed comparable resting cell length in cardiomyocytes from
WT and catalase transgenic mice. High fat feeding for 20 weeks signiﬁ-
cantly suppressed peak shortening (PS), maximum velocity of shorten-
ing/relengthening (±dL/dt) and prolonged time-to-90% relengthening
(TR90) without affecting time-to-PS (TPS). Although catalase transgene
itself did not alter the mechanical parameters tested, it ablated high fat
diet-induced cardiomyocyte mechanical changes (Fig. 1). To examine
the role of intracellular Ca2+ homeostasis in catalase overexpression
and/or high fat diet-induced cardiac mechanical responses, intracellular
Ca2+ handling was evaluated using fura-2 ﬂuorescence technique.
Our data revealed that high fat diet feeding signiﬁcantly decreased
electrically-stimulated rise in intracellular Ca2+ levels (ΔFFI) and
prolonged intracellular Ca2+ decay without affecting the resting intracel-
lular Ca2+, the effects of which were ablated by catalase overexpression.Fig. 3. Histological analysis and ROS levels in hearts fromWT and catalase transgenic mice fed
transverse myocardial section (×400); B: quantitative analysis of cardiomyocyte cross-se
SEM, n = 120–125 cells (panel B) or 14–16 ﬁelds (panel C) from 4 mice per group, *p bCatalase overexpression itself did not affect intracellular Ca2+ indices
tested (Fig. 2).
3.3. Effect of catalase overexpression on cardiac hypertrophy and ROS
production following high fat diet feeding
Consistent with the increased heart weight following high fat diet
feeding, cardiomyocyte cross-sectional area was signiﬁcantly elevated
following high fat diet feeding. Although catalase overexpression itself
failed to affect cardiomyocyte cross-sectional area, it attenuated high
fat diet-induced rise in cardiomyocyte cross-sectional area (Fig. 3A–B).
Our data further demonstrated elevated ROS production following
high fat diet feeding. Although catalase overexpression itself failed to
affect myocardial ROS production, it signiﬁcantly attenuated high fat
diet-induced rise in ROS production (Fig. 3C).
3.4. Effect of catalase overexpression on autophagy and autophagy signaling
following high fat diet feeding
To elucidate possible mechanisms of action behind catalase trans-
gene and/or high fat diet-induced cardiac derangements, autophagy
and autophagy regulatory signaling molecules were examined. Our
data depicted that fat diet intake signiﬁcantly suppressed myocardial
autophagy (Atg5 and LC3II-to-LC3I ratio although not Beclin-1) and au-
tophagy ﬂux (elevated autophagy adaptor protein p62) along with thelow or high fat diet for 20 weeks. A: Representative H&E staining micrographs displaying
ctional (transverse) area; and C: myocardial ROS levels using DCF staining. Mean ±
0.05 vs. WT-low fat group, #p b 0.05 vs. WT-high fat group.
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transgene itself did not affect myocardial autophagy or autophagy ﬂux
although it signiﬁcantly attenuated high fat diet-induced changes in au-
tophagy (Atg5 and LC3 ratio) and Rheb but not p62 accumulation
(Fig. 4).
Our observation revealed that high fat diet intake overtly suppressed
phosphorylation (absolute or normalized value) of IKKβ, AMPK and
TSC2 while promoting the phosphorylation of mTOR. Although catalase
transgene failed to affect phosphorylation of these autophagy signaling
molecules in low fat-fed mice, it ablated high fat intake-induced chang-
es in the phosphorylation of IKKβ, AMPK, TSC2 and mTOR (Fig. 5). Nei-
ther high fat diet nor catalase overexpression affected pan protein
expression of IKKβ, AMPK, TSC2 and mTOR (data not shown).
3.5. Effects of IKKβ inhibition as well as activation of AMPK and autophagy
on palmitic acid-induced changes in cardiomyocyte autophagy and
contractile function
To elucidate a role for IKKβ and AMPK in fat diet intake-induced car-
diac dysfunction, cardiomyocytes fromWTmice (fed low fat diet) were
treated with palmitic acid (75 μM) in the presence and absence of the
autophagy inducer rapamycin, the IKKβ inhibitor salicylate and AMPKFig. 4. Changes in autophagymarkers in hearts fromWT and catalase transgenic mice fed low o
ratio, p62, Rheb and GAPDH (loading control) using speciﬁc antibodies; B: Beclin-1; C: Atg5; D:
group, #p b 0.05 vs.WT-high fat group.activator AICAR. Our data shown in Fig. 6 revealed that palmitic acid
overtly suppressed cardiomyocyte autophagy and contractile function
as manifested by decreased LC3II-to-LC3I ratio, PS, ±dL/dt, and
prolonged TR90 without affecting TPS. Interestingly, palmitic acid-
induced changes in cardiomyocyte autophagy and contractile function
were signiﬁcantly alleviated or mitigated by rapamycin, AICAR and sa-
licylate. Little changes in cardiomyocyte autophagy and function were
noted for these pharmacological activators. Neither palmitic acid nor
the pharmacological regulators tested affected resting cardiomyocyte
cell length (data not shown).
4. Discussion
Although a number ofmechanisms have been speculated for high fat
diet-induced cardiac geometric and contractile changes including oxi-
dative stress, lipotoxicity, mitochondrial damage, and intracellular
Ca2+ mishandling [15–17], the precise mechanism(s) in particular the
interplay among these concurrent contributing factors behind fat diet-
induced obesity cardiomyopathy remains elusive. Our present study re-
vealed that the antioxidant catalase signiﬁcantly attenuated fat diet-
induced cardiac geometric and contractile anomalies along with sup-
pressed autophagy. Involvement of autophagy in high fat diet-inducedr high fat diet for 20 weeks. A: Representative gel blots for levels of Atg5, Beclin-1, LC3II/I
LC3I/II; E: p62; and F: Rheb.Mean± SEM, n=5–7mice per group, *p b 0.05 vs.WT-low fat
Fig. 5.Changes in autophagy regulatory signalingmolecules in hearts fromWT and catalase transgenicmice fed low or high fat diet for 20 weeks. A: phosphorylated IKKβ (pIKKβ)-to-IKKβ
ratio; B: phosphorylated AMPK (pAMPK)-to-AMPK ratio; C: phosphorylated TSC2 (pTSC2)-to-TSC2 ratio; and D: phosphorylated mTOR (pmTOR)-to-mTOR ratio. Insets: Representative
gel blots for levels of total or phosphorylated IKKβ, AMPK, TSC2 andmTOR (GAPDH used as loading control) using speciﬁc antibodies; Mean± SEM, n= 5–7mice per group, *p b 0.05 vs.
WT-low fat group, #p b 0.05 vs.WT-high fat group.
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cial effects from autophagy induction and AMPK activation against
palmitic acid-induced cardiomyocyte functional anomalies. Our data
further depicted that IKKβ inhibition protects against palmitic acid-
induced cardiomyocyte autophagy and contractile defect, suggesting a
role for IKKβ in fat diet-induced cardiac dysfunction. Taken together,
these results have collectively prompted for a likelihood action of anti-
oxidant and autophagy induction in the regulation of myocardial geom-
etry and function in fat diet-induced obesity and more importantly, the
therapeutic potential of autophagy in obesity cardiac complications.
High fat diet intake triggers hyperinsulinemia, dyslipidemia, insulin
resistance and onset of type 2 diabetes [23,37,39], all of which aremajor
risk factors for myocardial remodeling and dysfunction via sympathetic
overactivation, renin–angiotensin stimulation or intrinsic myopathic
changes [40]. Our high fat feeding regimen elicited elevated plasma
markers for insulin, and triglycerides in the absence of full-blown diabe-
tes as evidenced by unchanged blood glucose. More importantly, our
data revealed decreased myocardial contractile capacity in fat diet-
induced obese hearts, in line with earlier reports of compromisedmyo-
cardial function and geometry in diet-induced obesity [15–17]. Interest-
ingly, fat diet-induced cardiac remodeling (heart mass, heart size, and
cardiomyocyte cross-sectional area) and contractile dysfunction were
alleviated by the antioxidant catalase, favoring a permissive role foroxidative stress in fat diet-induced obesity cardiomyopathy. The cata-
lase enzyme did not exert any discernable “systemic effect” on body
weight, glucose metabolism, as well as plasma insulin and triglyceride
levels in the face of fat diet intake, suggesting that catalase-induced ben-
eﬁcial effect is not secondary to changes in systemic metabolic proﬁle.
Our experimental data revealed that catalase ameliorated diet-
induced obesity-associated suppression of autophagy as evidenced by
Atg5, LC3II-to-LC3I ratio and rise in the negative regulator of autophagy
Rheb but not accumulation of the autophagy adaptor protein p62. This
is accompanied by rescued phosphorylation of IKKβ, APMK and TSC2
along with the suppressed mTOR phosphorylation. These ﬁndings
were in line with the previous observation of impaired myocardial au-
tophagy and autophagy ﬂux (accumulation of p62) following high fat
diet intake [41]. The unchanged myocardial p62 levels between high
fat diet-fedWT and catalasemice suggest an unlikely role for autophagy
ﬂux in catalase enzyme-offered protection of cardiac autophagy and
contractile function. Furthermore, the possible role of AMPK and au-
tophagy in fat diet intake-induced cardiac anomalies was substantiated
by the fact that rapamycin and AMPK activation effectively negated
palmitic acid-induced changes in cardiomyocyte autophagy and func-
tion. These ﬁndings received further support from the IKKβ inhibition-
elicited protective effects against palmitic acid-induced loss in cardio-
myocyte autophagy and contractile capacity. These data favor the
Fig. 6. Effect of palmitic acid (PA) on cardiomyocyte autophagy and mechanical properties in the absence or presence of IKKβ inhibitor, AMPK activator or autophagy inducer.
Cardiomyocytes from WT mice were incubated with palmitic acid (75 μM) for 6 h in the presence or absence of the IKKβ inhibitor (phosphorylation stimulator) sodium salicylate
(5 mg/ml), the AMPK activator AICAR (500 μM) or the autophagy inducer rapamycin (20 μM) prior to assessment of cardiomyocyte function. A: Cardiomyocyte autophagy evaluated
using LC3II-to-LC3I ratio, insets: representative gel blots for levels of LC3 and GAPDH (loading control) using speciﬁc antibodies; B: peak shortening (normalized to resting cell length);
C:maximal velocity of shortening (+dL/dt); D:maximal velocity of relengthening (−dL/dt); E: time-to-PS (TPS); and F: time-to-90% relengthening (TR90). Mean± SEM, n=6 isolations
(panel A) or 62 cells per group, *p b 0.05 vs. control group, #p b 0.05 vs. PA group.
350 L. Liang et al. / Biochimica et Biophysica Acta 1852 (2015) 343–352notion that antioxidant catalase rescues against autophagy through a
mechanism involving IKKβ and AMPK to preserve cardiac homeostasis
in fat diet-induced obesity. The ability of the antioxidant catalase to res-
cue myocardial autophagy is consistent with the notion that oxidative
stress or ROSmay promote excessive autophagy induction leading to un-
desired changes in cardiac geometry and contractile function [42,43].
However, given that catalase acts as an enzyme to detoxify the oxidative
stress end product hydrogen peroxide (H2O2), our current study was un-
able to elucidate the potential redox signaling pathway(s) responsible for
the regulation of autophagy en route to changes in cardiac structure and
function. Recent evidence suggested that activation of NADPH oxidase 4
in the endoplasmic reticulum may promote cardiomyocyte autophagy
and survival during energy stress [44]. Further study is warranted to
examine the possible involvement of NADPH oxidase in fat diet-induced
induction of autophagy in the heart.
Our data suggest that fat diet-induced obesity inhibits autophagy
possibly via an IKKβ-AMPK-dependent mechanism. Loss of myocardial
AMPK activation was reported in obesity [28,45]. AMPK negative regu-
lates mTOR via a TSC2-mediated inhibition of Rheb, as supported byour data of suppressed AMPK phosphorylation in conjunction with up-
regulated Rheb following high fat diet intake. AMPK activation is well
known to facilitate autophagy through a TSC-Rheb-mediated inhibition
of mTOR en route to the maintenance of cardiac homeostasis [46,47].
Our present ﬁnding revealed dampened myocardial phosphorylation
of IKKβ in associationwith decreased phosphorylation of the IKK down-
stream signals AMPK-TSC2 in diet-induced obesity, the effect of which
was ameliorated or mitigated by catalase enzyme. This ﬁnding is in
line with the previous ﬁnding of suppressed IKKβ activity (phosphory-
lation) under oxidative stress (such as accumulation of free radicals or
fat diet intake in our current experimental setting) [48,49]. These
observations collectively provide a possible explanation for fat diet
intake- and catalase-mediated regulation of autophagy through an
IKKβ-AMPK-TSC-mTOR-dependent mechanism. A scheme is provided
in Fig. 7 to summarize the proposed mechanism of action involved in
fat diet- and catalase-induced regulation of cardiac autophagy, geome-
try and function. It should be pointed out that the involvement of
IKKβ-AMPK-TSC2-Rheb-mTOR pathway in the regulation of obesity
cardiomyopathy received convincing support from our in vitro ﬁnding
Fig. 7. Schematic diagram depicting possible mechanism(s) involved in high fat diet
intake- and catalase overexpression-induced changes in cardiac geometry, intracellular
Ca2+ homeostasis and contractile function. High fat diet intake suppressed activation of
IKKβ. Suppressed IKKβ phosphorylation inhibits activation of AMPK and the TSC complex
(through phosphorylation) to alleviate the inhibition on Rheb and mTOR, leading to
interrupted autophagy and autophagyﬂux. Catalase restores activation of IKKβ and subse-
quently AMPK activation, mTOR inhibition to preserve autophagy regulation and cardiac
homeostasis under fat diet intake. Arrows denote stimulation whereas the lines with a
“T” ending represent inhibition. IKKβ: IκB kinase β subunit; AMPK: AMP-activation pro-
tein kinase; TSC: tuber sclerosis complex; mTOR: mammalian target of rapamycin.
351L. Liang et al. / Biochimica et Biophysica Acta 1852 (2015) 343–352that salicylate reversed palmitic acid-induced cardiomyocyte dysfunc-
tion. Last but not the least, it is noteworthy that possible contribution
from other autophagy regulatory machineries such as JNK-mediated
phosphorylation of Bcl-2 to disengage the association between Bcl-2
and the autophagy protein Beclin-1 [50] cannot be excluded at this
time. Nonetheless, our data indicated unchanged levels of Beclin-1,
not favoring involvement of mTOR-independent regulation of autopha-
gy although future study is needed to consolidate possible involvement
(or non-involvement) of other autophagy regulatory pathways.
In conclusion, our ﬁnding suggests that catalase enzymemay rescue
against diet-induced cardiac geometric and contractile anomalies. These
ﬁndings support a pivotal role for oxidative stress in the regulation of
cardiac autophagy en route to cardiac homeostasis in fat diet-induced
obesity. Our data favor the notion that catalase rescues myocardial
autophagy possibly via an IKKβ-AMPK-TSC-Rheb-mTOR mechanism in
fat diet-induced obesity (Fig. 7). Although loss of the highly conserved
self-repair autophagy capacity is well known in obesity [23,41], our
data suggest a beneﬁcial role for antioxidant in the restoration of au-
tophagy. These ﬁndings support the beneﬁcial role for dietary polyphe-
nol antioxidants such as green tea catechins, resveratrol and curcumin
in the management of obesity and obesity-related complications [51].
Despite the pronounced effect fromanimal obesity studies includingde-
creases in body weight, fat mass and triglycerides through enhancing
energy expenditure and fat utilization, and modulating glucose hemo-
stasis, limited human evidence is available for dietary polyphenol anti-
oxidants to support the antiobesity impact possibly due to variations
in study designs and durations, and human subjects (age, gender, eth-
nicity) [51]. To this end, a better understanding of antioxidant-offered
beneﬁcial effects in cardiac geometry and function through autophagy
regulation should shed some lights towards a more effective therapeutic
application of antioxidant in the management of obesity and associated
cardiac anomalies.Competing interests
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